Xolair 150 MG/1.2 ML powder VLS
Ended Awarded
- Contract number
- SPE2DB25FM8HG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,737
Award facts
- Contract value 100% obligated
- $7,737.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,737.00 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order covers the supply of Xolair 150 mg/1.2 mL powder vials, a biologics medication used in the treatment of moderate-to-severe allergic asthma and other allergic conditions. This award was issued without a set-aside designation and carries an ultimate completion date of September 3, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at approximately $500 million and remains valid through November 2026. This IDC framework enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group's established position as a critical supplier in the federal pharmaceutical supply chain, combined with its woman-owned small business status, has enabled the company to secure consistent contracts for specialized pharmaceutical products and biologics distribution to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FM8HG?
SPE2DB25FM8HG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FM8HG worth?
The government has obligated $7,737 on SPE2DB25FM8HG.
Is contract SPE2DB25FM8HG an order under another contract?
Yes. SPE2DB25FM8HG is a delivery order under SPE2DB22D9151, an indefinite delivery contract.
Was contract SPE2DB25FM8HG competed?
The extent of competition for SPE2DB25FM8HG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award